Advertisement
Screener

VIATRIS INC. (VTRS) Quick Ratio

2.8 / 5 stars · 68/120 Roast Me

Viatris Inc Quick Ratio

The quick ratio is a stricter test of whether a company can pay the bills due within a year, counting only assets that are already cash or close to it. It is cash, marketable securities and receivables divided by current liabilities, shown as a multiple, with both amounts in the table. It is the current ratio with inventory and other assets that take longer to turn into cash removed, so it is never higher than the current ratio. A company that does not report one of the inputs has no point for that date rather than an estimated one. Quarterly points use quarter-end balances; annual points use fiscal-year-end balances.

  • Viatris Inc quick ratio for the quarter ending 2026-06-30 was 0.63, a 18.00% increase year-over-year.
  • Viatris Inc quick ratio for the quarter ending 2026-03-31 was 0.72, a 5.63% increase year-over-year.
  • Viatris Inc quick ratio for the quarter ending 2025-12-31 was 0.62, a 9.85% decline year-over-year.
  • Viatris Inc quick ratio for the quarter ending 2025-09-30 was 0.59, a 20.26% decline year-over-year.
  • Viatris Inc quick ratio for fiscal 2025 was 0.62, a 9.85% decline from fiscal 2024.
  • Viatris Inc quick ratio for fiscal 2024 was 0.68, a 13.45% increase from fiscal 2023.
  • Viatris Inc quick ratio for fiscal 2023 was 0.6, a 19.80% decline from fiscal 2022.
  • Viatris Inc quick ratio for fiscal 2022 was 0.75, a 49.59% increase from fiscal 2021.
Available history
2019-12-31 to 2026-06-30
Data captured

Historical Quick Ratio

DateQuick RatioQuick assetsCurrent liabilities
2026-06-300.63$4.02B$6.35B
2026-03-310.72$4.88B$6.81B
2025-12-310.62$4.38B$7.09B
2025-09-300.59$4.38B$7.36B
2025-06-300.54$3.83B$7.13B
2025-03-310.68$3.88B$5.72B
2024-12-310.68$3.96B$5.78B
2024-09-300.75$5.6B$7.51B
2024-06-300.58$4.49B$7.71B
2024-03-310.6$4.65B$7.76B
2023-12-310.6$4.69B$7.78B
2023-09-300.74$5.05B$6.83B
2023-06-300.65$4.24B$6.52B
2023-03-310.66$4.01B$6.11B
2022-12-310.75$5.08B$6.75B
2022-09-300.61$3.98B$6.52B
2022-06-300.57$4.41B$7.68B
2022-03-310.5$4.85B$9.64B
2021-12-310.5$4.97B$9.88B
2021-09-300.51$5.11B$10.1B
2021-06-300.51$5.16B$10.13B
2021-03-310.54$5.34B$9.98B
2020-12-310.54$5.69B$10.56B
2020-09-270$0.00$79M
2020-06-280$0.00$27.8M
2019-12-310.64$3.55B$5.57B

Annual Quick Ratio

DateQuick RatioQuick assetsCurrent liabilities
2025-12-310.62$4.38B$7.09B
2024-12-310.68$3.96B$5.78B
2023-12-310.6$4.69B$7.78B
2022-12-310.75$5.08B$6.75B
2021-12-310.5$4.97B$9.88B
2020-12-310.54$5.69B$10.56B
2019-12-310.64$3.55B$5.57B

Similar stocks

Stock NameCountryMarket CapPE Ratio
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17